US Stock MarketDetailed Quotes

Dr. Reddy's Laboratories (RDY)

Watchlist
  • 13.670
  • +0.090+0.66%
Close Apr 24 16:00 ET
  • 13.564
  • -0.106-0.78%
Post 20:01 ET
11.38BMarket Cap18.96P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Dr. Reddy's Laboratories (RDY) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Dec 31, 2025
(Q2)Sep 30, 2025
(Q1)Jun 30, 2025
(FY)Mar 31, 2025
(Q4)Mar 31, 2025
(Q3)Dec 31, 2024
(Q2)Sep 30, 2024
(Q1)Jun 30, 2024
(FY)Mar 31, 2024
(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
64.77%10.91B
67.16%15.57B
72.19%14.63B
2.19%46.43B
90.94%22B
39.75%6.62B
-48.03%9.32B
-24.48%8.5B
-22.83%45.43B
-41.46%11.52B
Net income from continuing operations
-15.25%11.9B
6.36%14.27B
1.26%14.1B
2.80%57.25B
21.44%15.87B
1.81%14.04B
-9.36%13.42B
-0.75%13.92B
23.56%55.68B
36.26%13.07B
Operating gains losses
68.88%-512M
-852.04%-2.1B
683.85%1.26B
3.35%-1.53B
212.03%177M
-675.17%-1.65B
79.98%-221M
126.61%161M
-43.60%-1.58B
60.50%-158M
Depreciation and amortization
10.47%5.21B
27.07%5.05B
25.07%4.77B
14.94%17.06B
22.65%4.55B
25.17%4.72B
4.91%3.98B
6.75%3.81B
17.45%14.84B
16.43%3.71B
Deferred tax
-24.91%3.53B
-29.03%4.08B
1.02%4.95B
20.72%19.54B
41.96%4.18B
5.28%4.7B
32.72%5.75B
10.43%4.9B
5.79%16.19B
-19.57%2.95B
Other non cash items
29.82%148M
-105.43%-5M
-104.11%-298M
126.81%152M
270.37%92M
160.32%114M
125.14%92M
-447.62%-146M
-328.63%-567M
55.00%-54M
Change In working capital
15.78%-8.13B
67.16%-2.56B
37.67%-8.19B
-48.59%-29.99B
121.14%584M
18.62%-9.65B
-398.35%-7.78B
-60.77%-13.14B
-156.93%-20.18B
-142.05%-2.76B
-Change in receivables
70.13%-2.35B
15.14%-2.88B
-511.58%-4.81B
-27.68%-10.28B
191.34%1.75B
11.04%-7.85B
-146.29%-3.4B
83.09%-786M
-40.02%-8.05B
-177.11%-1.92B
-Change in inventory
-103.78%-2.16B
59.35%-2.04B
2.74%-6.15B
30.86%-12.75B
90.70%-363M
79.65%-1.06B
-6.51%-5.01B
-36.33%-6.32B
-594.99%-18.45B
-3,124.79%-3.9B
-Change in payables and accrued expense
-25.23%-1.67B
66.96%2.64B
150.22%6.2B
-90.17%340M
-59.55%-2.39B
-441.54%-1.33B
-32.47%1.58B
11.47%2.48B
14,943.48%3.46B
-290.10%-1.5B
-Change in other working capital
-428.57%-1.96B
70.82%-281M
59.62%-3.44B
-355.27%-7.29B
-65.18%1.59B
-66.65%595M
59.35%-963M
-664.69%-8.51B
441.10%2.86B
-0.72%4.56B
Cash from discontinued investing activities
Operating cash flow
64.77%10.91B
67.16%15.57B
72.19%14.63B
2.19%46.43B
90.94%22B
39.75%6.62B
-48.03%9.32B
-24.48%8.5B
-22.83%45.43B
-41.46%11.52B
Investing cash flow
Cash flow from continuing investing activities
-88.57%-10.29B
49.96%-9.54B
5.22%-19.19B
-44.17%-58.08B
-17.18%-13.3B
66.27%-5.46B
-322.21%-19.07B
-145.85%-20.25B
2.63%-40.28B
28.04%-11.35B
Net PPE purchase and sale
5.52%-6.69B
30.20%-5.11B
-39.08%-6.83B
-75.97%-26.99B
-47.79%-7.67B
-113.92%-7.09B
-127.77%-7.33B
-35.64%-4.91B
-36.46%-15.34B
54.05%-5.19B
Net intangibles purchase and sale
70.79%-474M
-10,258.70%-4.67B
-150.08%-3.29B
44.04%-6.16B
-214.82%-3.27B
-34.58%-1.62B
119.66%46M
84.60%-1.31B
-45.98%-11.01B
86.23%-1.04B
Net business purchase and sale
--0
--0
---51M
-445,008.33%-53.41B
---1.66B
--0
---51.76B
--0
---12M
--0
Net investment purchase and sale
-256.68%-3.48B
-99.18%319M
31.85%-9.86B
259.95%25.12B
68.15%-1.77B
118.58%2.22B
2,338.67%39.13B
-507.03%-14.47B
32.79%-15.7B
54.80%-5.55B
Cash from discontinued investing activities
Investing cash flow
-88.57%-10.29B
49.96%-9.54B
5.22%-19.19B
-44.17%-58.08B
-17.18%-13.3B
66.27%-5.46B
-322.21%-19.07B
-145.85%-20.25B
2.63%-40.28B
28.04%-11.35B
Financing cash flow
Cash flow from continuing financing activities
1,218.14%7.78B
-132.96%-5.32B
-112.61%-1.2B
602.55%18.91B
-1,282.74%-7.37B
-88.83%590M
329.53%16.15B
746.41%9.54B
85.99%-3.76B
87.60%-533M
Net issuance payments of debt
470.87%8.68B
-85.71%2.37B
-102.49%-256M
433.73%23.2B
-4,821.10%-5.15B
-73.84%1.52B
2,920.27%16.56B
1,135.92%10.27B
121.31%4.35B
102.64%109M
Net common stock issuance
20.00%30M
-98.72%92M
931.58%196M
-248.57%-1.2B
-27,306.45%-8.43B
177.78%25M
948.69%7.19B
-75.95%19M
118.75%805M
-85.97%31M
Cash dividends paid
--0
0.05%-6.66B
--0
-0.21%-6.66B
--0
--0
-0.21%-6.66B
--0
-33.52%-6.65B
--0
Net other financing activities
----
----
----
--7.06B
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
1,218.14%7.78B
-132.96%-5.32B
-112.61%-1.2B
602.55%18.91B
-1,282.74%-7.37B
-88.83%590M
329.53%16.15B
746.41%9.54B
85.99%-3.76B
87.60%-533M
Net cash flow
Beginning cash position
-12.22%9.91B
83.27%9B
105.33%14.59B
22.98%7.11B
72.95%13.03B
-16.62%11.29B
-32.03%4.91B
22.98%7.11B
-61.09%5.78B
20.39%7.54B
Current changes in cash
379.05%8.39B
-88.94%707M
-160.79%-5.77B
423.58%7.26B
465.29%1.33B
128.44%1.75B
0.35%6.4B
-243.76%-2.21B
114.82%1.39B
7.40%-363M
Effect of exchange rate changes
7,260.00%358M
947.83%195M
941.18%177M
479.66%224M
461.54%235M
-103.11%-5M
65.15%-23M
119.10%17M
-120.63%-59M
26.14%-65M
End cash Position
43.16%18.66B
-12.22%9.91B
83.27%9B
105.33%14.59B
105.33%14.59B
72.95%13.03B
-16.62%11.29B
-32.03%4.91B
22.98%7.11B
22.98%7.11B
Free cash flow
263.17%3.59B
286.50%5.44B
116.31%4.48B
-33.16%12.03B
105.27%10.75B
-620.98%-2.2B
-89.94%1.41B
324.97%2.07B
-55.02%18B
-67.13%5.24B
Currency Unit
INR
INR
INR
INR
INR
INR
INR
INR
INR
INR
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Dec 31, 2025(Q2)Sep 30, 2025(Q1)Jun 30, 2025(FY)Mar 31, 2025(Q4)Mar 31, 2025(Q3)Dec 31, 2024(Q2)Sep 30, 2024(Q1)Jun 30, 2024(FY)Mar 31, 2024(Q4)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 64.77%10.91B67.16%15.57B72.19%14.63B2.19%46.43B90.94%22B39.75%6.62B-48.03%9.32B-24.48%8.5B-22.83%45.43B-41.46%11.52B
Net income from continuing operations -15.25%11.9B6.36%14.27B1.26%14.1B2.80%57.25B21.44%15.87B1.81%14.04B-9.36%13.42B-0.75%13.92B23.56%55.68B36.26%13.07B
Operating gains losses 68.88%-512M-852.04%-2.1B683.85%1.26B3.35%-1.53B212.03%177M-675.17%-1.65B79.98%-221M126.61%161M-43.60%-1.58B60.50%-158M
Depreciation and amortization 10.47%5.21B27.07%5.05B25.07%4.77B14.94%17.06B22.65%4.55B25.17%4.72B4.91%3.98B6.75%3.81B17.45%14.84B16.43%3.71B
Deferred tax -24.91%3.53B-29.03%4.08B1.02%4.95B20.72%19.54B41.96%4.18B5.28%4.7B32.72%5.75B10.43%4.9B5.79%16.19B-19.57%2.95B
Other non cash items 29.82%148M-105.43%-5M-104.11%-298M126.81%152M270.37%92M160.32%114M125.14%92M-447.62%-146M-328.63%-567M55.00%-54M
Change In working capital 15.78%-8.13B67.16%-2.56B37.67%-8.19B-48.59%-29.99B121.14%584M18.62%-9.65B-398.35%-7.78B-60.77%-13.14B-156.93%-20.18B-142.05%-2.76B
-Change in receivables 70.13%-2.35B15.14%-2.88B-511.58%-4.81B-27.68%-10.28B191.34%1.75B11.04%-7.85B-146.29%-3.4B83.09%-786M-40.02%-8.05B-177.11%-1.92B
-Change in inventory -103.78%-2.16B59.35%-2.04B2.74%-6.15B30.86%-12.75B90.70%-363M79.65%-1.06B-6.51%-5.01B-36.33%-6.32B-594.99%-18.45B-3,124.79%-3.9B
-Change in payables and accrued expense -25.23%-1.67B66.96%2.64B150.22%6.2B-90.17%340M-59.55%-2.39B-441.54%-1.33B-32.47%1.58B11.47%2.48B14,943.48%3.46B-290.10%-1.5B
-Change in other working capital -428.57%-1.96B70.82%-281M59.62%-3.44B-355.27%-7.29B-65.18%1.59B-66.65%595M59.35%-963M-664.69%-8.51B441.10%2.86B-0.72%4.56B
Cash from discontinued investing activities
Operating cash flow 64.77%10.91B67.16%15.57B72.19%14.63B2.19%46.43B90.94%22B39.75%6.62B-48.03%9.32B-24.48%8.5B-22.83%45.43B-41.46%11.52B
Investing cash flow
Cash flow from continuing investing activities -88.57%-10.29B49.96%-9.54B5.22%-19.19B-44.17%-58.08B-17.18%-13.3B66.27%-5.46B-322.21%-19.07B-145.85%-20.25B2.63%-40.28B28.04%-11.35B
Net PPE purchase and sale 5.52%-6.69B30.20%-5.11B-39.08%-6.83B-75.97%-26.99B-47.79%-7.67B-113.92%-7.09B-127.77%-7.33B-35.64%-4.91B-36.46%-15.34B54.05%-5.19B
Net intangibles purchase and sale 70.79%-474M-10,258.70%-4.67B-150.08%-3.29B44.04%-6.16B-214.82%-3.27B-34.58%-1.62B119.66%46M84.60%-1.31B-45.98%-11.01B86.23%-1.04B
Net business purchase and sale --0--0---51M-445,008.33%-53.41B---1.66B--0---51.76B--0---12M--0
Net investment purchase and sale -256.68%-3.48B-99.18%319M31.85%-9.86B259.95%25.12B68.15%-1.77B118.58%2.22B2,338.67%39.13B-507.03%-14.47B32.79%-15.7B54.80%-5.55B
Cash from discontinued investing activities
Investing cash flow -88.57%-10.29B49.96%-9.54B5.22%-19.19B-44.17%-58.08B-17.18%-13.3B66.27%-5.46B-322.21%-19.07B-145.85%-20.25B2.63%-40.28B28.04%-11.35B
Financing cash flow
Cash flow from continuing financing activities 1,218.14%7.78B-132.96%-5.32B-112.61%-1.2B602.55%18.91B-1,282.74%-7.37B-88.83%590M329.53%16.15B746.41%9.54B85.99%-3.76B87.60%-533M
Net issuance payments of debt 470.87%8.68B-85.71%2.37B-102.49%-256M433.73%23.2B-4,821.10%-5.15B-73.84%1.52B2,920.27%16.56B1,135.92%10.27B121.31%4.35B102.64%109M
Net common stock issuance 20.00%30M-98.72%92M931.58%196M-248.57%-1.2B-27,306.45%-8.43B177.78%25M948.69%7.19B-75.95%19M118.75%805M-85.97%31M
Cash dividends paid --00.05%-6.66B--0-0.21%-6.66B--0--0-0.21%-6.66B--0-33.52%-6.65B--0
Net other financing activities --------------7.06B------------------------
Cash from discontinued financing activities
Financing cash flow 1,218.14%7.78B-132.96%-5.32B-112.61%-1.2B602.55%18.91B-1,282.74%-7.37B-88.83%590M329.53%16.15B746.41%9.54B85.99%-3.76B87.60%-533M
Net cash flow
Beginning cash position -12.22%9.91B83.27%9B105.33%14.59B22.98%7.11B72.95%13.03B-16.62%11.29B-32.03%4.91B22.98%7.11B-61.09%5.78B20.39%7.54B
Current changes in cash 379.05%8.39B-88.94%707M-160.79%-5.77B423.58%7.26B465.29%1.33B128.44%1.75B0.35%6.4B-243.76%-2.21B114.82%1.39B7.40%-363M
Effect of exchange rate changes 7,260.00%358M947.83%195M941.18%177M479.66%224M461.54%235M-103.11%-5M65.15%-23M119.10%17M-120.63%-59M26.14%-65M
End cash Position 43.16%18.66B-12.22%9.91B83.27%9B105.33%14.59B105.33%14.59B72.95%13.03B-16.62%11.29B-32.03%4.91B22.98%7.11B22.98%7.11B
Free cash flow 263.17%3.59B286.50%5.44B116.31%4.48B-33.16%12.03B105.27%10.75B-620.98%-2.2B-89.94%1.41B324.97%2.07B-55.02%18B-67.13%5.24B
Currency Unit INRINRINRINRINRINRINRINRINRINR
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -